Unit
- Obesity as a chronic disease: The American Medical Association recognized obesity as a chronic disease in 2013, shifting focus from short-term weight loss to long-term management, similar to hypertension or diabetes.
- Pathophysiology overview: Obesity results from genetic, environmental, psychological, and physiological factors that disrupt energy balance and alter weight-regulating mechanisms.
- Energy balance model: Weight change depends on calorie intake versus expenditure, but metabolic adaptations and hormonal signals make sustained weight loss challenging.
- Set point theory: The body defends a certain weight range through compensatory mechanisms, leading to weight regain after diet-induced loss.
- Obesity classification: Body mass index (BMI) is a screening tool with categories: overweight (25-29.9), class I (30-34.9), class II (35-39.9), class III (40+). Waist circumference adds metabolic risk information.
- Chronic disease model: Obesity requires ongoing care, monitoring, and treatment adjustment. Remission is possible but recurrence is common without sustained intervention.
- Impact on health: Obesity increases risk for over 200 conditions, including type 2 diabetes, cardiovascular disease, certain cancers, and mental health disorders.
- Stigma and bias: Weight stigma in healthcare can discourage patients from seeking care. Providers must adopt a patient-centered, non-judgmental approach.
- Adipose tissue biology: Adipose tissue functions as an active endocrine organ, secreting hormones and cytokines such as leptin, adiponectin, and resistin. In obesity, adipose tissue undergoes hyperplasia and hypertrophy, leading to hypoxia, macrophage infiltration, and chronic low-grade inflammation. This dysfunctional state promotes insulin resistance, dyslipidemia, and systemic metabolic derangements that drive obesity related comorbidities.
- Metabolic syndrome clustering: Metabolic syndrome is a cluster of interconnected risk factors including central obesity, elevated triglycerides, reduced HDL cholesterol, hypertension, and impaired fasting glucose. The presence of three or more criteria significantly raises the risk for type 2 diabetes and cardiovascular disease. Management of obesity directly improves metabolic syndrome components, highlighting the importance of integrated treatment.
- Pharmacotherapeutic options: Pharmacotherapy for obesity includes a growing number of FDA approved medications that target appetite and satiety pathways. Agents such as phentermine topiramate, naltrexone bupropion, liraglutide, and semaglutide have demonstrated efficacy with mean weight loss of 5 to 15 percent. Selection is guided by patient comorbidities, medication tolerability, and contraindications. Long term use is often needed for sustained benefit.
- Behavioral interventions: Behavioral interventions form the cornerstone of obesity treatment and include dietary modifications, increased physical activity, and cognitive behavioral strategies. Evidence supports the use of self monitoring, goal setting, stimulus control, and problem solving. Intensive programs with at least 14 sessions over 6 months achieve clinically significant weight loss. Motivational interviewing and shared decision making enhance patient engagement and adherence.
- Pediatric obesity considerations: Pediatric obesity requires careful assessment using BMI percentiles and consideration of growth, comorbidities, and family history. The American Academy of Pediatrics recommends comprehensive, family based lifestyle interventions. For children aged 12 and older with obesity, pharmacotherapy may be considered in addition to lifestyle modification. Early treatment prevents progression of metabolic complications and reduces the likelihood of adult obesity.
Scope of Practice
Role: Primary Care Physician in Obesity Medicine
Within scope:
- Screening for obesity using BMI and waist circumference during annual visits
- Providing initial counseling on lifestyle modifications
- Prescribing FDA-approved anti-obesity medications when appropriate
- Referral to
Quick Revision
- Review the key concepts covered in Defining Obesity as a Chronic Disease.
- Apply these principles in practical working contexts.
- Connect this material to the wider module objectives.